Expert Review of Molecular Diagnostics

Papers
(The TQCC of Expert Review of Molecular Diagnostics is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
LAMP Diagnostics at the Point-of-Care: Emerging Trends and Perspectives for the Developer Community141
The dark side of lipid metabolism in prostate and renal carcinoma: novel insights into molecular diagnostic and biomarker discovery44
Advances in tests for colorectal cancer screening and diagnosis43
Rapid lateral flow tests for the detection of SARS-CoV-2 neutralizing antibodies42
The diagnostic and prognostic role of neutrophil-to-lymphocyte ratio in COVID-19: a systematic review and meta-analysis40
Critical insight into recombinase polymerase amplification technology38
Noninvasive detection of COPD and Lung Cancer through breath analysis using MOS Sensor array based e-nose37
Developing multiplex ddPCR assays for SARS-CoV-2 detection based on probe mix and amplitude based multiplexing34
Role of N6-methyladenosine modification in pathogenesis of ischemic stroke32
Diagnosis for COVID-19: current status and future prospects31
Enzymatic cross-linking of collagens in organ fibrosis – resolution and assessment26
Emerging circulating MiRNAs and LncRNAs in upper gastrointestinal cancers25
Ultrasensitive circulating tumor DNA analysis enables precision medicine: experimental workflow considerations25
Liquid biopsy in head and neck squamous cell carcinoma: circulating tumor cells, circulating tumor DNA, and exosomes24
An overview of using fungal DNA for the diagnosis of invasive mycoses23
Antimicrobial resistance prediction in Neisseria gonorrhoeae: current status and future prospects23
Predictive biomarkers of response to immune checkpoint inhibitors in hepatocellular carcinoma23
Saliva as a sample type for SARS-CoV-2 detection: implementation successes and opportunities around the globe22
Advances in RT-LAMP for COVID-19 testing and diagnosis22
Liquid biopsy from research to clinical practice: focus on non-small cell lung cancer22
Blood-based traumatic brain injury biomarkers – Clinical utilities and regulatory pathways in the United States, Europe and Canada22
A review on current diagnostic techniques for COVID-1922
Nanomaterial-based Optical and Electrochemical Biosensors for Amyloid beta and Tau: Potential for early diagnosis of Alzheimer’s Disease22
Aptamer-based sensing of breast cancer biomarkers: a comprehensive review of analytical figures of merit22
Metabolomics-based predictive biomarkers of radiation injury and countermeasure efficacy: current status and future perspectives22
Circulating tumor cell clusters: Insights into tumour dissemination and metastasis21
Concentration of cell-free DNA in different tumor types21
Predictive biomarkers for systemic therapy of hepatocellular carcinoma20
Advances in gold nanoparticle technology as a tool for diagnostics and treatment of cancer19
Performance comparison of the Cobas® Liat® and Cepheid® GeneXpert® systems on SARS-CoV-2 detection in nasopharyngeal swab and posterior oropharyngeal saliva19
RAD51 as a functional biomarker for homologous recombination deficiency in cancer: a promising addition to the HRD toolbox?19
A review on human body fluids for the diagnosis of viral infections: scope for rapid detection of COVID-1919
Diagnostic salivary biomarkers in oral cancer and oral potentially malignant disorders and their relationships to risk factors – A systematic review18
dPCR application in liquid biopsies: divide and conquer18
Human tear fluid analysis for clinical applications: progress and prospects18
Emerging Role of Extracellular Vesicles in Biomarking the Gastrointestinal Diseases17
Recent advances in the diagnosis monkeypox: implications for public health17
Tumor treating fields: a comprehensive overview of the underlying molecular mechanism17
Diagnostic and Prognostic Significance of Dysregulated Expression of Circular RNAs in Osteosarcoma17
Circulating microRNA biomarkers in melanoma and non-melanoma skin cancer16
A profile of the binx health io® molecular point-of-care test for chlamydia and gonorrhea in women and men16
Future potential of metagenomics in microbiology laboratories16
Metabolic profile of the Warburg effect as a tool for molecular prognosis and diagnosis of cancer16
Mid-regional pro-adrenomedullin as a supplementary tool to clinical parameters in cases of suspicion of infection in the emergency department16
Potential of CRISPR/Cas system in the diagnosis of COVID-19 infection16
Quantifying SARS-CoV-2 viral load: current status and future prospects15
Improving laboratory diagnostics in myasthenia gravis15
Brain tumors and circulating micrornas: a systematic review and diagnostic meta-analysis15
Exploring the real-world effect of the SARS-CoV-2 pandemic on the molecular diagnostics for cancer patients and high-risk individuals15
Molecular charcterization of lung adenocarcinoma combining whole exome sequencing, copy number analysis and gene expression profiling15
Application of selected biosensor techniques in clinical diagnostics15
Dysregulation of lncRNA-H19 in cardiometabolic diseases and the molecular mechanism involved : a systematic review15
MicroRNA-217: a therapeutic and diagnostic tumor marker15
The importance of genomic analysis in cracking the coronavirus pandemic14
Identification of the candidate lncRNA biomarkers for acute kidney injury: a systematic review and meta-analysis14
Noninvasive prenatal screening for fetal sex chromosome aneuploidies14
Recent advances in the diagnosis of COVID-19: a bird’s eye view14
Research tests for the diagnosis of tuberculosis infection14
Quantitative versus qualitative estrogen and luteinizing hormone testing for personal fertility monitoring14
Applications of the CRISPR-Cas system for infectious disease diagnostics13
The clinical application of metagenomic next-generation sequencing for detecting pathogens in bronchoalveolar lavage fluid: case reports and literature review13
True or false: what are the factors that influence COVID-19 diagnosis by RT-qPCR?13
The diagnostic accuracy of seven commercial molecular in vitro SARS-CoV-2 detection tests: a rapid meta-analysis13
Oral Potentially Malignant Disorders (OPMD): What is the clinical utility of dysplasia grade?13
Diagnostic accuracy of cerebrospinal fluid and serum-isolated extracellular vesicles for glioblastoma: a systematic review and meta-analysis13
Common markers of testicular Sertoli cells13
Impact of non-antibiotic drugs on the human intestinal microbiome13
Viral metagenomic sequencing in the diagnosis of meningoencephalitis: a review of technical advances and diagnostic yield12
Optimizing testing regimes for the detection of COVID-19 in children and older adults12
Cell-free DNA as a potential biomarker for preeclampsia12
microRNAs as novel diagnostic biomarkers in endometriosis patients: a systematic review and meta-analysis12
Point-of-care COVID-19 testing in the emergency department: current status and future prospects12
Spatial profiling technologies and applications for brain cancers12
Unveiling the underpinnings of various non-conventional ELISA variants: a review article11
Rapid metagenomics for diagnosis of bloodstream and respiratory tract nosocomial infections: current status and future prospects11
An update on current and novel molecular diagnostics for the diagnosis of invasive fungal infections11
ASSURED-SQVM diagnostics for COVID-19: addressing the why, when, where, who, what and how of testing11
Assessing our approach to diagnosing Fibromyalgia10
Construction of a 5-methylcytosine-Related Molecular Signature to Inform the Prognosis and Immunotherapy of Lung Squamous Cell Carcinoma10
Radiomics and theranostics with molecular and metabolic probes in prostate cancer: toward a personalized approach10
Advancing cervical cancer diagnosis and screening with spectroscopy and machine learning10
Utility of droplet digital PCR and NGS-based CNV clinical assays in hearing loss diagnostics: current status and future prospects10
Point-of-care testing for viral-associated pulmonary aspergillosis10
Salivary biomarkers associated with obstructive sleep apnea: a systematic review10
Current and future strategies for diagnostic and management of obstructive sleep apnea10
Brain exosomes as minuscule information hub for Autism Spectrum Disorder9
The relationship between positivity for COVID-19 RT-PCR and symptoms, clinical findings, and mortality in Turkey9
Investigation of LOY in Prostate, Pancreatic, and Colorectal Cancers in males: A case–control study9
Long non-coding RNAs and their potential impact on diagnosis, prognosis, and therapy in prostate cancer: racial, ethnic, and geographical considerations9
Updates in diagnosing polycystic ovary syndrome-related infertility9
Using lipocalin as a prognostic biomarker in acute kidney injury9
At-home coronavirus testing: the next game-changer?9
The potential diagnostic value of extracellular vesicle miRNA for human non-small cell lung cancer: a systematic review and meta-analysis9
Diagnostic value of monocyte to high-density lipoprotein ratio in acute aortic dissection in a Chinese han population9
Highly sensitive droplet digital PCR-based diagnostics for the surveillance of malaria vector populations in low transmission and incipient resistance settings9
Nuclease activity: an exploitable biomarker in bacterial infections9
Current and emerging biomarkers for ulcerative colitis9
The detrimental impact of elevated Ferritin to Iron ratio on in-hospital prognosis of patients with COVID-199
Recent advances in rapid antimicrobial susceptibility testing systems9
Neuroimaging with PET/CT in chronic traumatic encephalopathy: what nuclear medicine can do to move the field forward9
The prenatal exome – a door to prenatal diagnostics?9
Beyond the Usual Suspects: Expanding on Mutations and Detection for Familial Hypercholesterolemia9
Protein array-based companion diagnostics in precision medicine8
A systematic review and meta-analysis on the relative and attributable risk of Helicobacter pylori infection and cardia and non-cardia gastric cancer8
Screening for ROS1 fusions in patients with advanced non-small cell lung carcinomas using the VENTANA ROS1 (SP384) Rabbit Monoclonal Primary Antibody8
Clinical utility of therapy selection informed by predicted nonresponse to tumor necrosis factor-ɑ inhibitors: an analysis from the Study to Accelerate Information of Molecular Signatures (AIMS) in rh8
A profile of the FDA-approved and CE/IVD-marked AptimaMycoplasma genitaliumassay (Hologic) and key priorities in the management ofM. genitaliuminfections8
A computational prognostic model of lncRNA signature for clear cell renal cell carcinoma with genome instability8
Insight into diagnosis of female genital tuberculosis8
Blood concentrations of proapoptotic sFas and antiapoptotic Bcl2 and COVID-19 patient mortality8
Toward an individualized determination of dialysis adequacy: a narrative review with special emphasis on incremental hemodialysis8
Polygenic and Network-based studies in risk identification and demystification of cancer8
Liquid biopsy derived circulating tumor cells and circulating tumor DNA as novel biomarkers in hepatocellular carcinoma8
Molecular imaging in immuno-oncology: current status and translational perspectives8
Challenges in diagnosing hydatidiform moles: a review of promising molecular biomarkers8
Advances in the diagnosis of autoimmune diseases based on citrullinated peptides/proteins8
0.04839015007019